{
    "nctId": "NCT04815616",
    "briefTitle": "Efficacy of Capecitabine With Adjuvant Radiotherapy in Treatment of Early Stages Breast Cancer (Retrospective Study).",
    "officialTitle": "Efficacy of Capecitabine With Adjuvant Radiotherapy in Treatment of Early Stages Breast Cancer (Retrospective Study).",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 47,
    "primaryOutcomeMeasure": "Disease free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age of patients \u2265 18 years old patients.\n2. Histopathology confirmed: invasive ductal carcinoma.\n3. Breast conservative surgery or mastectomy.\n4. Early stage breast cancer patients.\n5. Adjuvant chemotherapy in the form of Anthracyclins based.\n\nExclusion Criteria:\n\n1. Contraindications to radiotherapy: such as previous irradiation to chest wall or skin diseases.\n2. Pregnancy or lactation.\n3. Contraindications to capecitabine such as: severe renal impairment Or hypersensitivity to capecitabine.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}